Frequently Asked Questions

---

At Vista Statistics, we proudly serve a diverse range of clients, providing comprehensive consulting and solutions tailored to meet their unique needs. Our expertise extends across various domains, including:

• Clinical Trial Design: We specialize in offering valuable insights and support for the design of robust clinical trials, ensuring precision and efficiency in the drug development process.
• Companion Diagnostic (CDx) Development: Vista Statistics is committed to aiding in the development of cutting-edge Companion Diagnostics, fostering advancements in personalized medicine.
• Biostatistics Solutions: Our team excels in providing Biostatistics solutions encompassing protocol development, Statistical Analysis Plans (SAP), and Clinical Study Reports (CSR), contributing to the generation of reliable and meaningful results.
• Bioinformatics Solutions: Leveraging our expertise, we offer advanced bioinformatics solutions for Next-Generation Sequencing (NGS) data analyses, empowering clients with in-depth insights into genomics and molecular biology.

Vista Statistics is dedicated to supporting startups on their journey to success by providing tailored consulting and solution services. Our expertise extends across various areas critical to the growth and development of innovative ventures. Here are the key consulting services we offer for startups:

• Statistical Guidance for Product Development:
  • We provide strategic statistical guidance to help startups navigate the complexities of product development, ensuring robust methodologies from conception to market launch.
• Clinical Trial Design and Optimization:
  • Vista Statistics collaborates with startups to design and optimize clinical trials, offering insights that maximize efficiency, data quality, and regulatory compliance.
• Biostatistics Solutions for Regulatory Submissions:
  • Our team assists startups in preparing robust Biostatistics solutions for regulatory submissions, facilitating a smooth pathway through the approval process.
• Customized Data Analysis and Interpretation:
  • We offer customized data analysis solutions tailored to the unique needs of startups, providing actionable insights that drive informed decision-making.
• Strategic Advice on Companion Diagnostic (CDx) Development:
  • For startups involved in CDx development, Vista Statistics offers strategic advice and support to navigate the intricacies of companion diagnostics, aligning with personalized medicine goals.
• Bioinformatics Support for Genomic Data:
  • Leveraging our bioinformatics expertise, we assist startups in analyzing and interpreting genomic data, unlocking valuable insights for research and development.

The Vista Statistics team brings a wealth of experience and expertise to the drug industry, contributing to various facets of pharmaceutical and biotechnological advancements. Here's an overview of our team's extensive experience:

• Clinical Trial Design and Execution:
  • Our team members have actively participated in the design and execution of numerous clinical trials, ensuring methodological rigor, regulatory compliance, and the successful progression of drug development programs.
• Biostatistics Solutions:
  • Vista Statistics experts have a proven track record in providing Biostatistics solutions for drug development, including the creation of robust Statistical Analysis Plans (SAP), protocol development, and the generation of comprehensive Clinical Study Reports (CSR).
• Regulatory Submissions Support:
  • We have successfully supported regulatory submissions, collaborating closely with clients to prepare and present statistical and data-related documentation to regulatory authorities.
• Companion Diagnostic (CDx) Development:
  • Our team has played a pivotal role in guiding and supporting Companion Diagnostic (CDx) development, aligning with the evolving landscape of personalized medicine.
• Bioinformatics for Genomic Data Analysis:
  • Vista Statistics experts specialize in bioinformatics solutions, particularly in the analysis and interpretation of genomic data, contributing to advancements in understanding molecular mechanisms and treatment strategies.